Cara Therapeutics Inc. buy klostergang
Start price
03.04.17
/
50%
€16.64
Target price
23.06.17
€20.75
Performance (%)
24.80%
End price
23.06.17
€20.77
Summary
This prediction ended on 23.06.17 with a price of €20.77. The prediction had a final performance of 24.80%. klostergang has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Cara Therapeutics Inc. | 0.787% | 0.787% | -88.758% | -96.738% |
iShares Core DAX® | -0.598% | 0.645% | 10.813% | 15.396% |
iShares Nasdaq 100 | -3.290% | -4.193% | 23.772% | 40.773% |
iShares Nikkei 225® | -0.796% | -0.582% | 8.390% | 8.288% |
iShares S&P 500 | -1.164% | -0.857% | 23.003% | 41.152% |
Comments by klostergang for this prediction
In the thread Cara Therapeutics Inc. diskutieren
klostergang stimmt der Buy-Einschätzung von marge zu
klostergang stimmt am 03.04.2017 der Buy-Einschätzung von marge mit dem Kursziel 23$ zu.Überschrift: marge stimmt der Buy-Einschätzung von datca zu
(Zielkurs erreicht)
Stopped prediction by klostergang for Cara Therapeutics Inc.
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€14.51
30.06.17
30.06.17
€18.94
27.06.18
27.06.18
2.18%
27.06.18
27.06.18